EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A score system to determine the 5-year survival in patients with asymptomatic carotid stenosis under best medical therapy: Results from the Carotid Asymptomatic Stenosis study

Marcello Lodato, Rodolfo Pini, Cristina Rocchi, Enrico Gallitto, Andrea Vacirca, Mauro Gargiulo, Gianluca Faggioli

Journal of Vascular Surgery · 2026

DOI: 10.1016/j.jvs.2026.06.003 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Marcello Lodato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy. Electronic address: marcello.lodato7@gmail.com. Hauptthemen laut MEDLINE: Carotid Stenosis, Platelet Aggregation Inhibitors. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Current international guidelines do not recommend carotid revascularization in patients with asymptomatic carotid artery stenosis (ACAS) with a life expectancy less than 5 years or high-risk clinical conditions. However, improvements in medical therapy leading to a reduction of cerebral ischemic events risk may improve long-term survival. After a previous report of 5-year cerebral ischemic event outcomes in a prospective observational study of patients with ACAS treated with best medical therapy (BMT), the long-term survival in the same population was evaluated. METHODS: This was a prospective (NCT04825080; Carotid Asymptomatic Stenosis Study) observational cohort study including patients with ACAS > 60% (North American Symptomatic Carotid Endarterectomy Trial criteria) started in 2019 and ended in 2025. Patients were not considered for carotid revascularization due to high surgical risk or the absence of plaque vulnerability features. BMT was defined as regular intake of antiplatelet therapy and statins, blood pressure control, and cessation/absence of smoking. Follow-up included annual clinical visits and 6-month telephone interviews. The primary endpoint was overall survival, stratified by age (≤80, 81-85, and >85 years). Secondary analyses aimed to identify independent predictors of mortality and to develop a mortality risk score. RESULTS: A total of 307 patients were included (mean age, 80 ± 7 years; 55% male). Contralateral carotid stenosis > 60% was present in 61 patients (20%). At the end of follow-up, 86% of patients were under BMT. The overall transient ischemic attack /stroke rate was 1.3% per year, with higher risk for contralateral stenosis (1.9%) and plaque progression (1.8%). The overall 5-year survival rate was 80 ± 2%, with age-related differences: 90 ± 2% in patients ≤ 80 years, 75 ± 4% in those aged 81 to 85 years and 67 ± 6% in patients > 85 years (P 85 years (HR, 3.5; 95% CI, 2.1-5.8; P 85 years. Receiver-operating characteristic curve analysis identified a score ≥ 3 as highly specific for patients at high risk (area under the curve, 75%). Patients with a score > 3 had significantly lower 5-year survival (52%) compared with those with a score ≤3 (87%; P < .001). CONCLUSIONS: In patients with ACAS under BMT, 5-year survival is high, and it is driven more by comorbid clinical conditions than by advanced age alone. These findings may help refine patient selection and risk stratification when considering carotid revascularization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid StenosisPlatelet Aggregation InhibitorsHumansMaleFemaleProspective StudiesAsymptomatic DiseasesRisk FactorsAged, 80 and overRisk AssessmentTime FactorsAgedTreatment OutcomePredictive Value of TestsStrokeHydroxymethylglutaryl-CoA Reductase Inhibitors

Stichwörter der Autor:innen

BMTCarotid artery stenosisMortality score

Substanzen

Platelet Aggregation InhibitorsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy. Electronic address: marcello.lodato7@gmail.com.
  • Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy; Vascular Surgery, University of Bologna DIMEC, Bologna, Italy.
  • Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy.

Zitieren

APA

Lodato, M., Pini, R., Rocchi, C., Gallitto, E., Vacirca, A., Gargiulo, M., & Faggioli, G. (2026). A score system to determine the 5-year survival in patients with asymptomatic carotid stenosis under best medical therapy: Results from the Carotid Asymptomatic Stenosis study. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2026.06.003

Vancouver

Lodato M, Pini R, Rocchi C, Gallitto E, Vacirca A, Gargiulo M, et al. A score system to determine the 5-year survival in patients with asymptomatic carotid stenosis under best medical therapy: Results from the Carotid Asymptomatic Stenosis study. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2026.06.003

BibTeX
@article{Lodato2026,
  author = {Lodato, Marcello and Pini, Rodolfo and Rocchi, Cristina and Gallitto, Enrico and Vacirca, Andrea and Gargiulo, Mauro and Faggioli, Gianluca},
  title = {A score system to determine the 5-year survival in patients with asymptomatic carotid stenosis under best medical therapy: Results from the Carotid Asymptomatic Stenosis study},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2026.06.003}
}
Kostenlos starten →